ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MSYS Microsaic Systems Plc

1.05
0.00 (0.00%)
Last Updated: 08:00:28
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Microsaic Systems Plc LSE:MSYS London Ordinary Share GB00BMWC8365 ORD GBP0.00001
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.05 1.00 1.10 1.05 1.00 1.05 197,259 08:00:28
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Electronic Components, Nec 1.57M -2.29M -0.0128 -0.82 1.88M

Microsaic Systems plc Notice of Results (9753W)

07/08/2018 7:01am

UK Regulatory


Microsaic Systems (LSE:MSYS)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Microsaic Systems Charts.

TIDMMSYS

RNS Number : 9753W

Microsaic Systems plc

07 August 2018

7 August 2018

Microsaic Systems plc

("Microsaic", "Microsaic Systems" or the "Company")

Notice of Results

Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, will announce its results for the six months to 30 June 2018 on Monday 3 September 2018.

 
 Enquiries: 
 Microsaic Systems plc 
  Glenn Tracey, CEO 
  Bevan Metcalf, FD                    +44 (0) 1483 751 577 
 
   N+1 Singer (Nominated Adviser & 
   Broker) 
   Shaun Dobson 
   Liz Yong                             +44 (0)20 7496 3000 
 IFC Advisory Ltd (Financial PR) 
  Graham Herring 
  Heather Armstrong 
  Florence Chandler                     +44 (0)20 3934 6630 
 

About Microsaic Systems

Microsaic Systems plc (AIM: MSYS) is a high technology company developing and commercialising chip-based, bench-top and point-of-analysis mass spectrometry ("MS") instruments that are designed to improve the efficiency of pharmaceutical R&D and manufacturing. The Company is working with established global life science companies to co-develop new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines. MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.

Microsaic's core product, the 4500 MiD(R), is a robust and compact MS system, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. For more information, please go to www.microsaic.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NORLLFSETRIRIIT

(END) Dow Jones Newswires

August 07, 2018 02:01 ET (06:01 GMT)

1 Year Microsaic Systems Chart

1 Year Microsaic Systems Chart

1 Month Microsaic Systems Chart

1 Month Microsaic Systems Chart

Your Recent History

Delayed Upgrade Clock